Frontline vs Navios Maritime Partners L.P.
FRO and NMM side by side, both in water transportation. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FRO and NMM compare
Navios Maritime Partners L.P. grew revenue faster over the last twelve months (0.76% versus −8.8% for Frontline).
Frontline scores higher on the StockData Score (5 against 4 for Navios Maritime Partners L.P.), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FRO | NMM |
|---|---|---|
| Size and price | ||
| Share price | $56.90 | $91.03 |
| Change, 1 year | 130% | 96.5% |
| Change, 5 years | 560% | 212% |
| Beta (5Y) | 0.83 | 0.85 |
| Employees | 85 | 1,000 |
| StockData Score | ||
| Total score | 5 (better) | 4 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 1 | 1 |
| Health score | 3 (better) | 2 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −8.8% | 0.76% (better) |
| Revenue growth, 5Y average | 10.0% | 42.7% (better) |
| Net income growth (TTM) | – | −22.3% |
| EPS growth (TTM) | −23.8% | – |
| EPS growth, 5Y average | −4.0% | – |
| Profitability | ||
| Gross margin | – | 90.5% |
| Operating margin | 30.4% | – |
| Net margin | – | 21.2% |
| FCF margin | 34.0% | – |
| Return on invested capital | 11.0% | – |
| Financial health | ||
| Debt / equity | 0.77 | – |
| Net debt / EBITDA | 3.53 | – |
| Interest coverage | 2.6× | – |
| Current ratio | 1.87 (better) | 1.53 |
| Piotroski F-score | – | 5 |
| Dividends and buybacks | ||
| Payout ratio | – | 2.1% |
| Ownership | ||
| Held by institutions | 29.1% | 33.9% |
| Held by insiders | 35.6% | 27.7% |
| Insider net buying, 12 months | – | $854M |
| Short interest, % of float | 6.3% | 2.4% |
Go deeper
- FRO stock overview
- FRO income statement
- FRO valuation and score
- NMM stock overview
- NMM income statement
- NMM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.